Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents

Tomohiro Hikata, Tomoka Hasegawa, Keisuke Horiuchi, Nobuyuki Fujita, Akio Iwanami, Koota Watanabe, Ken Ishii, Masaya Nakamura, Norio Amizuka, Morio Matsumoto

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Minimodeling is a type of focal bone formation that is characterized by the lack of precedent bone erosion by osteoclasts. Although this form of bone formation has been described for more than a decade, how anti-osteoporotic agents that are currently used in clinical practice affect the kinetics of minimodeling is not fully understood. We performed a bone morphometric analysis using human vertebral specimens collected from postmenopausal patients who underwent spinal surgery. Patients were divided into three groups according to osteoporosis medication; non-treated, Eldecalcitol (ELD, a vitamin D derivative that has recently been approved to treat patients with osteoporosis in Japan)-treated, and bisphosphonate-treated groups. Five to six patients were enrolled in each group. There was a trend toward enhanced minimodeling in ELD-treated patients and suppressed of it in bisphosphonate-treated patients compared with untreated patients. The differences of minimodeling activity between ELD-treated and bisphosphonate-treated patients were statistically significant. The present study suggests that ELD and bisphosphonates have opposite effects on minimodeling from one another, and show that minimodeling also takes place in vertebrae as has been described for the ilium and femoral head in humans.

Original languageEnglish
Pages (from-to)286-291
Number of pages6
JournalBone Reports
Volume5
DOIs
Publication statusPublished - 2016 Dec 1

Fingerprint

Spine
Diphosphonates
Osteogenesis
Osteoporosis
Ilium
Bone and Bones
Osteoclasts
Thigh
Vitamin D
Japan

Keywords

  • Bisphosphonates
  • Eldecalcitol
  • Minimodeling
  • Osteoporosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents. / Hikata, Tomohiro; Hasegawa, Tomoka; Horiuchi, Keisuke; Fujita, Nobuyuki; Iwanami, Akio; Watanabe, Koota; Ishii, Ken; Nakamura, Masaya; Amizuka, Norio; Matsumoto, Morio.

In: Bone Reports, Vol. 5, 01.12.2016, p. 286-291.

Research output: Contribution to journalArticle

@article{1d59eed061a7496396baea1c4f4af659,
title = "Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents",
abstract = "Minimodeling is a type of focal bone formation that is characterized by the lack of precedent bone erosion by osteoclasts. Although this form of bone formation has been described for more than a decade, how anti-osteoporotic agents that are currently used in clinical practice affect the kinetics of minimodeling is not fully understood. We performed a bone morphometric analysis using human vertebral specimens collected from postmenopausal patients who underwent spinal surgery. Patients were divided into three groups according to osteoporosis medication; non-treated, Eldecalcitol (ELD, a vitamin D derivative that has recently been approved to treat patients with osteoporosis in Japan)-treated, and bisphosphonate-treated groups. Five to six patients were enrolled in each group. There was a trend toward enhanced minimodeling in ELD-treated patients and suppressed of it in bisphosphonate-treated patients compared with untreated patients. The differences of minimodeling activity between ELD-treated and bisphosphonate-treated patients were statistically significant. The present study suggests that ELD and bisphosphonates have opposite effects on minimodeling from one another, and show that minimodeling also takes place in vertebrae as has been described for the ilium and femoral head in humans.",
keywords = "Bisphosphonates, Eldecalcitol, Minimodeling, Osteoporosis",
author = "Tomohiro Hikata and Tomoka Hasegawa and Keisuke Horiuchi and Nobuyuki Fujita and Akio Iwanami and Koota Watanabe and Ken Ishii and Masaya Nakamura and Norio Amizuka and Morio Matsumoto",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.bonr.2016.10.002",
language = "English",
volume = "5",
pages = "286--291",
journal = "Bone Reports",
issn = "2352-1872",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Histomorphometric analysis of minimodeling in the vertebrae in postmenopausal patients treated with anti-osteoporotic agents

AU - Hikata, Tomohiro

AU - Hasegawa, Tomoka

AU - Horiuchi, Keisuke

AU - Fujita, Nobuyuki

AU - Iwanami, Akio

AU - Watanabe, Koota

AU - Ishii, Ken

AU - Nakamura, Masaya

AU - Amizuka, Norio

AU - Matsumoto, Morio

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Minimodeling is a type of focal bone formation that is characterized by the lack of precedent bone erosion by osteoclasts. Although this form of bone formation has been described for more than a decade, how anti-osteoporotic agents that are currently used in clinical practice affect the kinetics of minimodeling is not fully understood. We performed a bone morphometric analysis using human vertebral specimens collected from postmenopausal patients who underwent spinal surgery. Patients were divided into three groups according to osteoporosis medication; non-treated, Eldecalcitol (ELD, a vitamin D derivative that has recently been approved to treat patients with osteoporosis in Japan)-treated, and bisphosphonate-treated groups. Five to six patients were enrolled in each group. There was a trend toward enhanced minimodeling in ELD-treated patients and suppressed of it in bisphosphonate-treated patients compared with untreated patients. The differences of minimodeling activity between ELD-treated and bisphosphonate-treated patients were statistically significant. The present study suggests that ELD and bisphosphonates have opposite effects on minimodeling from one another, and show that minimodeling also takes place in vertebrae as has been described for the ilium and femoral head in humans.

AB - Minimodeling is a type of focal bone formation that is characterized by the lack of precedent bone erosion by osteoclasts. Although this form of bone formation has been described for more than a decade, how anti-osteoporotic agents that are currently used in clinical practice affect the kinetics of minimodeling is not fully understood. We performed a bone morphometric analysis using human vertebral specimens collected from postmenopausal patients who underwent spinal surgery. Patients were divided into three groups according to osteoporosis medication; non-treated, Eldecalcitol (ELD, a vitamin D derivative that has recently been approved to treat patients with osteoporosis in Japan)-treated, and bisphosphonate-treated groups. Five to six patients were enrolled in each group. There was a trend toward enhanced minimodeling in ELD-treated patients and suppressed of it in bisphosphonate-treated patients compared with untreated patients. The differences of minimodeling activity between ELD-treated and bisphosphonate-treated patients were statistically significant. The present study suggests that ELD and bisphosphonates have opposite effects on minimodeling from one another, and show that minimodeling also takes place in vertebrae as has been described for the ilium and femoral head in humans.

KW - Bisphosphonates

KW - Eldecalcitol

KW - Minimodeling

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=84992065929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992065929&partnerID=8YFLogxK

U2 - 10.1016/j.bonr.2016.10.002

DO - 10.1016/j.bonr.2016.10.002

M3 - Article

VL - 5

SP - 286

EP - 291

JO - Bone Reports

JF - Bone Reports

SN - 2352-1872

ER -